Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines

scientific article published in June 1990

Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0264-410X(90)90051-M
P698PubMed publication ID2363300

P50authorDavid TyrrellQ3018902
P2093author name stringRobinson BS
Watt PJ
Pringle CR
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectantibodyQ79460
P304page(s)231-236
P577publication date1990-06-01
P1433published inVaccineQ7907941
P1476titleDeterminants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines
P478volume8

Reverse relations

cites work (P2860)
Q39398631Analysis of respiratory syncytial virus strain variation in successive epidemics in one city
Q45460509Antigen-dependent proliferation and cytokine induction in respiratory syncytial virus-infected cotton rats reflect the presence of effector-memory T cells
Q33801890CD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment
Q45480836Comparison of affinity chromatography and adsorption to vaccinia virus recombinant infected cells for depletion of antibodies directed against respiratory syncytial virus glycoproteins present in a human immunoglobulin preparation.
Q38790481Controlled human infection with RSV: The opportunities of experimental challenge
Q45742833Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H.
Q45872879Epitope specificities of human serum antibodies reactive with respiratory syncytial virus fusion protein
Q35091812Feasibility of aerosol vaccination in humans
Q35618515Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus
Q36539394Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses
Q33683058Intranasal antibody prophylaxis for protection against viral disease.
Q40076730Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus
Q35823116Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice
Q36689031Live vaccines for human metapneumovirus designed by reverse genetics
Q36692801Live-attenuated respiratory syncytial virus vaccines
Q34191801Molecular epidemiology of respiratory syncytial virus
Q47340692Mothers may transmit RSV infection more easily or severely to sons than daughters: community study from Guinea-Bissau
Q39695161Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein.
Q42207071Polyclonal and monoclonal antibodies specific for the six-helix bundle of the human respiratory syncytial virus fusion glycoprotein as probes of the protein post-fusion conformation.
Q45722102Prevalence of anti-human respiratory syncytial virus antibodies over three consecutive years in a healthy adult population.
Q56894869Progress in respiratory virus vaccine development
Q40836386Respiratory syncytial virus (RSV) disease and prospects for its control
Q33961877Respiratory syncytial virus infection in adults
Q43617842Respiratory syncytial virus vaccine: a systematic overview with emphasis on respiratory syncytial virus subunit vaccines
Q45377065Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.
Q64117055Systematic comparison of respiratory syncytial virus-induced memory B cell responses in two anatomical compartments
Q35108669Using mathematical transmission modelling to investigate drivers of respiratory syncytial virus seasonality in children in the Philippines
Q35843602Vaccines for neonatal viral infections: towards a live respiratory syncytial virus vaccine:a study in risk
Q24201977Vaccines for the common cold
Q38682527Vaccines for the common cold

Search more.